G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $132 | -78.4% | 49,297 | -56.3% | 0.00% | -83.3% |
| Q4 2022 | $612 | -99.9% | 112,746 | +34.0% | 0.01% | -47.8% |
| Q3 2022 | $1,051,000 | +373.4% | 84,119 | +87.1% | 0.02% | +283.3% |
| Q2 2022 | $222,000 | -62.2% | 44,964 | +37.9% | 0.01% | -64.7% |
| Q4 2020 | $587,000 | +90.0% | 32,607 | +22.0% | 0.02% | +30.8% |
| Q3 2020 | $309,000 | +13.2% | 26,732 | +411.4% | 0.01% | +85.7% |
| Q3 2018 | $273,000 | – | 5,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |